Nasopharyngeal carriage of resistant pneumococci in young South Indian infants

Epidemiology and Infection

Volumn 129, Issue 3, 2002, Pages 491-497

  Coles, C L ^a   Rahmathullah, L ^b   Kanungo, R ^c   Thulasiraj, R D ^d   Katz, J ^a   Santosham, M ^a   Tielsch, J M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Aravind Centre for Women Children and Community Health   (India)

^c JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

^d Madurai   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ERYTHROMYCIN; OXACILLIN; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIAL STRAIN; BACTERIUM CARRIER; BACTERIUM ISOLATE; CONTROLLED STUDY; HEALTH CARE PERSONNEL; HUMAN; INDIA; INFANT; MULTIDRUG RESISTANCE; NASOPHARYNX; PRESCRIPTION; REVIEW; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0036976280     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0950268802007586     Document Type: Review

References (24)

1. WHO. Vaccine research and development: report of the technical review group meeting, 9-10 June 1997. WHO/VRD/GEN/09.01. Geneva: WHO, 1997; 32-56.
2. Shann F. Steinhoff MC. Vaccines for children in rich and poor countries. Lancet 1999; 354 (Suppl 2): SII7-11.
3. WHO. Vaccine research and development: report of the technical review group meeting, 7-8 June 1998 (WHO/VRD/GEN/98.02). Geneva: WHO, 1 January 1998; 1-78.
4. WHO. Etiology and clinical signs of serious infections in young infants in developing countries: a WHO collaborative study. Pediatr Infect Dis J 1999; 18: S1-69.
5. Hart CA, Kariuki S. Antimicrobial resistance in developing countries. BMJ 1998; 317: 647-50.
6. Butler JC, Dowell SF, Breiman RF. Epidemiology of emerging pneumococcal drug resistance: implications for treatment and prevention. Vaccine 1998; 16: 1693-7.
7. Anonymous. Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Lancet 1999; 353: 1216-21.
8. Jebaraj R, Cherian T, Raghupathy P, Brahmadathan KN, Lalitha MK, Thomas K, Steinhoff MC. Nasopharyngeal colonization of infants in southern India with Streptococcus pneumoniae. Epidemiol Infect 1999; 123: 383-8.
9. Lehmann D, Gratten M, Montgomery J. Susceptibility of pneumococcal carriage isolates to penicillin provides a conservative estimate of susceptibility of invasive pneumococci. Pediatr Infect Dis J 1997; 16: 297-305.
10. Kellner JD, McGeer A, Cetron MS, Low DE, Butler JC, Matlow A, Talbot J, Ford-Jones EL. The use of Streptococcus pneumoniae nasopharyngeal isolates from healthy children to predict features of invasive disease. Pediatr Infect Dis J 1998; 17: 279-86.
11. Mastro TD, Nomani NK, Ishaq Z, et al. Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J 1993; 12: 824-30.
12. Jorgensen JH, Doern GV, Maher LA, Howell AW, Redding JS. Antimicrobial resistance among respiratory isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae in the United States. Antimicrob Agents Chemother 1990; 34: 2075-80.
13. Coles CL, Rahmathullah L, Kanungo R, Thulasiraj RD, Katz J, Santhosham M, Tielsch JM. Vitamin A supplementation at birth delays pneumococcal colonization in South Indian infants. J Nutr 2001; 131: 255-61.
14. Lalitha MK, Thomas K, Kumar RS, Steinhoff MC. Serotyping of Streptococcus pneumoniae by coagglutination with 12 pooled antisera. J Clin Microbiol 1999; 37: 263-5.
15. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility tests, 8th ed. Villanova, PA: NCCLS, 1998.
16. Woolfson A, Huebner R, Wasas A, Chola S, Godfrey-Faussett P, Klugman K. Nasopharyngeal carriage of community-acquired, antibiotic-resistant Streptococcus pneumoniae in a Zambian paediatric population. Bull WHO 1997; 75: 453-62.
17. Gratten M, Gratten H, Poli A, Carrad E, Raymer M, Koki G. Colonisation of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage, and relationship to carriage in mothers. Biology Neonate 1986; 50: 114-20.
18. Lloyd-Evans N, O'Dempsey TJ, Baldeh I, et al. Nasopharyngeal carriage of pneumococci in Gambian children and in their families. Pediatr Infect Dis J 1996; 15: 866-71.
19. Yagupsky P, Porat N, Fraser D, Prajgrod F, Merires M, McGee L, Klugman KP, Dagan R. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 1998; 177: 1003-12.
20. Emele FE, Ahanotu CN, Anyiwo CE. Nasopharyngeal carriage of meningococcus and meningococcal meningitis in Sokoto, Nigeria. Acta Paediatr 1999; 88: 265-9.
21. Shinefield HR, Black S, Ray P, et al. Safety and immunogenicity of heptavalent pneumococcal CRM 197 conjugate vaccine in infants and toddlers [In Process Citation]. Pediatr Infect Dis J 1999; 18: 757-63.
22. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999; 180: 1171-6.
23. Eskola J, Anttila M. Pneumococcal conjugate vaccines. Pediatr Infect Dis J 1999; 18: 543-51.
24. Kalin M. Pneumococcal serotypes and their clinical relevance. Thorax 1998; 53: 159-62.